课题基金 / 基金详情

MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics

MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics
MalariSense:透皮无血、无试剂疟疾诊断
批准号:
9764243
负责人:
Umberto D'Alessandro
金额:
$47.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-17 至 2021-07-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
 描述:每天有近100万人因疟疾而患病,而严重的疟疾每年夺去60万人的生命。一种坚固、便携、灵敏和准确的诊断疟疾的方法,不需要抽血和使用试剂,将是理想的,并解决了现场或无症状病例疟疾诊断的关键问题。MalariSense技术能够在几秒钟内通过皮肤做出诊断,而不需要使用试剂或针头来获取血液。该设备的工作原理是照射一种短而安全的激光脉冲,该脉冲可以穿透皮肤到小血管。这种疟疾寄生虫体内有一种晶体,能够吸收激光能量,形成一个小的蒸汽纳米气泡,然后膨胀和坍塌。坍塌的蒸汽纳米气泡产生一种能够被超声波探测器检测到的压力波。未受感染的红细胞不会受到激光的影响,也不会产生蒸汽泡。在动物和人类身上,通过向耳朵照射激光并检测声音ping,证明了MalariSense的概念。在这个项目中,已发现的机制将转化为一种现场、易于使用的诊断设备,在几秒钟内非侵入性地检测有症状和无症状的疟疾感染,并使用一台诊断成本低于0.1美元的设备每年对20万人进行筛查。这将通过几项相互关联的活动实现:(1)确定MalariSense技术的方法和规格;(2)为现场使用开发MalariSense技术并制作其原型;(3)在流行地区评估MalariSense技术,确定其性能和应用,并开发全球疟疾筛查平台。还将开发和测试用于分析蚊子、血液样本和小动物的应用程序通过皮肤对疟疾进行敏感诊断的能力为疟疾诊断开辟了一个全新的维度。其影响和应用是多方面的。诊断和治疗生活在疟疾地区的无症状人群的能力将极大地有助于从该地区消除疟疾的战略。该设备的另一个方面是能够在全球范围内立即获取和分析原始数据,以便远程监测疟疾感染情况。所开发的软件、协议和设备将作为今后实施全球疟疾诊断系统的平台,以从根本上改善多种环境下的疟疾控制和消除。每年只有1000个单位将对2亿人进行筛查,以覆盖所有当前的疾病病例。
英文摘要
 DESCRIPTION: Almost a million people are ill from malaria each day while severe malaria disease claims the lives of 600,000 people each year. A rugged, portable sensitive and accurate method to diagnose malaria without blood sampling and using the reagents would be ideal and addresses the critical problem of malaria diagnosis in field or in asymptomatic cases. The MalariSense technology is able to make a diagnosis through the skin within seconds without using reagents or a needle to obtain blood. The device works by shining a short safe laser pulse that penetrates the skin to small blood vessels. The malaria parasite has a crystal inside of itsel that is able to absorb the laser energy to make a small vapor nanobubble that expands and collapses. The collapsing vapor nanobubble generates a pressure wave that is able to be detected by an ultrasound detector. Uninfected red blood cells are not affected by the laser and do not make a vapor bubble. The proof of MalariSense concept was demonstrated in animals and humans by shining a laser on the ear and detecting the sound pings. In this project, the discovered mechanism will be translated into a field, easy-to-use diagnostic device to non- invasively detect both symptomatic and asymptomatic malaria infections in seconds, and to screen > 200,000 people per year with a single device with a diagnosis cost below 0.1$. This will be achieved through several connected activities: (1) Determine the methodology and specifications for the MalariSense technology; (2) Develop and prototype the MalariSense technology for field use; (3) Evaluate the MalariSense technology in endemic area, determine its performance and applications, and develop the platform for a global screening of malaria. The applications for analyzing mosquitoes, blood samples and small animals will also be developed and tested the ability to make the sensitive diagnosis of malaria through the skin opens up a whole new dimension to malaria diagnosis. The impact and applications are many. The ability to diagnose and treat asymptomatic people living in malaria areas will help greatly the strategies to eliminate malaria from regions. Another dimension of the device is the ability to enable the immediate global access and analysis of the raw data for the remote monitoring of malaria infection. The developed software, protocol and device will act as a platform for the future implementation of the global malaria diagnostic system to radically improve the malaria control and elimination in multiple settings. Just 1000 units will annually screen 200 million people to cover all current disease cases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金